Crossmark

Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations

Crossref DOI link: https://doi.org/10.1038/s41375-018-0056-6

Published Online: 2018-02-26

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Willekens, Christophe

Renneville, Aline

Broutin, Sophie

Saada, Véronique

Micol, Jean-Baptiste

Delahousse, Julia

Poinsignon, Vianney https://orcid.org/0000-0002-4945-5431
Bories, Claire

Berthon, Céline

Itzykson, Raphael

Boissel, Nicolas

Quivoron, Cyril

Terroir-Cassou-Mounat, Marie

Bosq, Jacques

Preudhomme, Claude

Paci, Angelo

Penard-Lacronique, Virginie

De Botton, Stéphane
License Information

Text and Data Mining valid from 2018-02-26
More Information

Article History

Received: 30 November 2017

Revised: 8 January 2018

Accepted: 12 January 2018

First Online: 26 February 2018

Compliance with ethical standards

:

: SDB has conflict of interest with AGIOS and CELGENE. No potential conflicts of interest were disclosed by the other authors.